• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2010 Fiscal Year Final Research Report

Mechanistic analysis on DNA methylation in colorectal cancer and its application to diagnosis and therapy

Research Project

  • PDF
Project/Area Number 20390353
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionKanazawa University

Principal Investigator

KAWAKAMI Kazuyuki  Kanazawa University, がん研究所, 准教授 (00293358)

Co-Investigator(Kenkyū-buntansha) MINAMOTO Toshinari  金沢大学, がん研究所, 教授 (50239323)
Co-Investigator(Renkei-kenkyūsha) SOGA Tomoyoshi  慶應義塾大学, 環境情報学部, 教授 (60338217)
ISHIGAKI Yasuhito  金沢医科大学, 総合医学研究所, 講師 (20232275)
Project Period (FY) 2008 – 2010
Keywords大腸がん / メチル化 / 抗がん剤
Research Abstract

We investigated the clinical value of methylation profile for the prognosis of colorectal cancer (CRC) and for the survival benefit from adjuvant chemotherapy with oral fluoropyrimidines. CpG island methylator phenotype (CIMP) was relatively rare in Japan and its clinical value is limited. In contrast, methylation of long interspersed nuclear element-1 (LINE-1) was a potential predictive marker for survival benefit from adjuvant chemotherapy with oral fluoropyrimidines in CRC patients. CRC cell lines treated with 5-FU showed increased expression of LINE-1 mRNA. This was associated with upregulation of the phospho-histone H2A. X in cells with low LINE-1 methylation, but not in cells with high LINE-1 methylation. The 5-FU-mediated induction of phospho-histone H2A. X, a marker of DNA damage, was inhibited by knockdown of LINE-1. These findings could be important for achieving personalized chemotherapy.

  • Research Products

    (21 results)

All 2011 2010 2009 2008 Other

All Journal Article (7 results) (of which Peer Reviewed: 7 results) Presentation (12 results) Remarks (1 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer.2011

    • Author(s)
      Kawakami K, (他4名), Minamoto T.
    • Journal Title

      Cancer Sci 102

      Pages: 166-174

    • Peer Reviewed
  • [Journal Article] Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.2010

    • Author(s)
      Saito K, Kawakami K (他3名), Minamoto T.
    • Journal Title

      Clin Cancer Res 16

      Pages: 2418-2426

    • Peer Reviewed
  • [Journal Article] Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans.2010

    • Author(s)
      Peterson AJ, Kawakami K, Minamoto T, (他8名).
    • Journal Title

      Gastroenterology 139

      Pages: 2005-2017

    • Peer Reviewed
  • [Journal Article] Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels.2009

    • Author(s)
      Jin MJ, Kawakami K, (他6名), Minamoto T.
    • Journal Title

      Cancer Sci 100

      Pages: 2325-2330

    • Peer Reviewed
  • [Journal Article] Deregulated glycogen synthase kinase 3β sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase.2009

    • Author(s)
      Mai W, Kawakami K, (他7名), Minamoto T.
    • Journal Title

      Clin Cancer Res 15

      Pages: 6810-6819

    • Peer Reviewed
  • [Journal Article] Low expression of γ -glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype.2008

    • Author(s)
      Kawakami K, (他7名), Minamoto T.
    • Journal Title

      Br J Cancer 98

      Pages: 1555-1561

    • Peer Reviewed
  • [Journal Article] Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients : is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup?2008

    • Author(s)
      Iacopetta B, Kawakami K, Watanabe T.
    • Journal Title

      Int J Clin Oncol 13

      Pages: 498-503

    • Peer Reviewed
  • [Presentation] LINE-1 methylation is stable in primary and synchronous metastatic colorectal cancer tissues.2010

    • Author(s)
      松之木愛香, 川上和之, (他3名), 源利成.
    • Organizer
      第69回日本癌学会学術集会
    • Place of Presentation
      大阪国際会議場(大阪府)
    • Year and Date
      2010-09-23
  • [Presentation] Distinct DNA methylation profiles and genetic signatures in human colorectal cancer.2010

    • Author(s)
      小竹優範, 川上和之, (他4名), 源利成.
    • Organizer
      第69回日本癌学会学術集会
    • Place of Presentation
      大阪国際会議場(大阪府).
    • Year and Date
      2010-09-23
  • [Presentation] ヒト消化管がん組織検体資源化によるがん研究と個別化医療への応用:Project Kの試み.2010

    • Author(s)
      小竹優範, (他8名), 川上和之, 源利成.
    • Organizer
      第65回日本消化器外科学会総会
    • Place of Presentation
      海峡メッセ下関(山口県).
    • Year and Date
      2010-07-14
  • [Presentation] LINE-1 hypomethylation is a marker of poor prognosis in stage IAnon-small cell lung cancer.2010

    • Author(s)
      斎藤健一郎, 川上和之, (他3名), 源利成.
    • Organizer
      101^<st> Annual Meeting of American Association for Cancer Research
    • Place of Presentation
      Washington Convention Center (USA)
    • Year and Date
      2010-04-19
  • [Presentation] LINE-1メチル化解析による大腸がんの予後・抗癌剤感受性診断.2009

    • Author(s)
      川上和之, 源利成.
    • Organizer
      第20回消化器癌発生学会総会
    • Place of Presentation
      オリエンタルホテル広島(広島県)
    • Year and Date
      2009-11-26
  • [Presentation] DNAメチル化マーカーによる大腸がんの予後・抗癌剤感受性診断.2009

    • Author(s)
      川上和之, 源利成.
    • Organizer
      第17回日本消化器関連学会週間(JDDw 2009)/第51回日本消化器病学会大会
    • Place of Presentation
      国立京都国際会館(京都府)
    • Year and Date
      2009-10-15
  • [Presentation] TheCpG islamd methylator phenotype as a predictor of response to 5FU-based chemotherapy in colon cancer.2009

    • Author(s)
      Iacopetta B, Kawakami K
    • Organizer
      第68回日本癌学会総会学術集会
    • Place of Presentation
      パシフィコ横浜(神奈川県)
    • Year and Date
      2009-10-03
  • [Presentation] Augmentation of LINE-1 expression is apossible mechanism underling cytotoxic effect of 5-FU in colorectal cancer.2009

    • Author(s)
      川上和之, (他4名), 源利成.
    • Organizer
      第68回日本癌学会総会学術集会
    • Place of Presentation
      パシフィコ横浜(神奈川県)
    • Year and Date
      2009-10-02
  • [Presentation] Allele-specific inhibition of thymidylate synthase expression by small interfering RNA.2009

    • Author(s)
      川上和之, (他4名), 源利成.
    • Organizer
      Annual Meeting 2009 0f the American Association for Cancer Research
    • Place of Presentation
      Colorado Convention Center(USA)
    • Year and Date
      2009-04-20
  • [Presentation] LINE-1 hypomethylation is a novel prognostic factor in non-small cell lung cancer.2008

    • Author(s)
      斎藤健一郎, 川上和之, (他3名), 源利成.
    • Organizer
      第67回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2008-10-29
  • [Presentation] 遺伝子多型とアレル欠失を利用した癌特異的治療開発.2008

    • Author(s)
      川上和之, (他4名), 源利成.
    • Organizer
      第19回日本消化器癌発生学会総会
    • Place of Presentation
      別府 亀の井ホテル(大分県)
    • Year and Date
      2008-08-28
  • [Presentation] Methylation level of LINE-1 repeats as a prognostic factor for the patients with primary colorectal cancer.2008

    • Author(s)
      川上和之, (他5名), 源利成.
    • Organizer
      Annual Meeting 2008 of the American Association for Cancer Research
    • Place of Presentation
      San Diego Convention Center (USA)
    • Year and Date
      2008-04-14
  • [Remarks] ホームページ等

    • URL

      http://www.kanazawa-u.ac.jp/~ganken/shuyoseigyo/index.html

  • [Patent(Industrial Property Rights)] 癌患者の外科的手術後の治療選択方法及び予後診断2008

    • Inventor(s)
      川上和之,源利成
    • Industrial Property Rights Holder
      金沢大学
    • Industrial Property Number
      特許,特願2008-264695
    • Filing Date
      2008-10-01

URL: 

Published: 2012-01-26   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi